AGP Picks
View all

Fresh news on health and wellness in Washington, D.C.

Provided by AGP

Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on May 5, 2026

Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline
PathAI and A.C.Camargo Cancer Center Announce Cooperation to Expand Digital Pathology with AI in Brazil via SUS
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results
Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026
Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
[Latest] Digestive Health Supplements Market Size Expected to Reach USD 25.86 Billion by 2034 With 6.10% CAGR, Driven by Rising Geriatric Population Worldwide and Increasing Prevalence of Digestive Health Concerns
Neuronetics Reports First Quarter 2026 Financial and Operating Results
Discure Technologies Appoints Dr. Ray Baker to its Board of Directors
Kura Oncology to Report First Quarter 2026 Financial Results
Intellia Therapeutics to Participate in Upcoming Investor Conferences
Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update 
BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE
Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance
Tris Pharma Appoints Jim Potenziano, Ph.D. as Chief Science and Development Officer
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy
Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights
What to Look for in a Deodorant in Canada in 2026
Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

Share us

on your social networks:

Sign up for:

Potomac Health News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.